Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness analysis and the formulary decision-making process.

Zhixiao Wang1, J Warren Salmon, Surrey M Walton

  • 1Department of Pharmacy Administration, University of Illinois at Chicago, 60612, USA.

Journal of Managed Care Pharmacy : JMCP
|January 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association analysis between floc image information and coagulation efficiency based on partial least squares.

Environmental technology·2026
Same author

NSUN2 restrains renal fibrosis via m5C-stabilized GPX4 and ferroptosis inhibition.

Cellular signalling·2026
Same author

Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis Treatment.

American journal of clinical dermatology·2026
Same author

Inferior-Lead Lambda (λ) Wave Revealing Critical Right Coronary Artery Stenosis: A Case Report.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2026
Same author

Long-term Efficacy of Dupilumab Versus Tezepelumab in Asthma: A Matching-Adjusted Indirect Comparison.

The journal of allergy and clinical immunology. In practice·2026
Same author

Delayed complete atrioventricular block 11 months after transcatheter aortic valve replacement in a patient with a short membranous septum: a case report.

Frontiers in cardiovascular medicine·2026
Same journal

Should eligibility for medication therapy management be based on drug adherence?

Journal of managed care pharmacy : JMCP·2014
Same journal

Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden.

Journal of managed care pharmacy : JMCP·2014
Same journal

Pharmacists' role in the care of patients with heart failure: review and future evolution.

Journal of managed care pharmacy : JMCP·2014
Same journal

PCMHs, ACOs, and medication management: lessons learned from early research partnerships.

Journal of managed care pharmacy : JMCP·2014
Same journal

Adherence to national recommendations for safe methotrexate dispensing in community pharmacies.

Journal of managed care pharmacy : JMCP·2014
Same journal

Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel.

Journal of managed care pharmacy : JMCP·2014
See all related articles

Pharmacoeconomic evaluations, like cost-effectiveness analysis (CEA), are vital for managed care formularies. Enhancements to CEA methods will improve its practical use in decision-making for cost containment and quality care.

Area of Science:

  • Pharmacoeconomics
  • Health Economics
  • Health Services Research

Background:

  • Managed care formularies increasingly rely on pharmacoeconomic evaluations due to rising drug costs and cost containment pressures.
  • Cost-effectiveness analysis (CEA) is a primary pharmacoeconomic method, but current limitations hinder its practical application in formulary processes.
  • Advancements in analytical methods are expected to enhance the relevance and utility of CEA over time.

Purpose of the Study:

  • To review cost-effectiveness analysis (CEA), including its limitations and applications.
  • To promote the greater utility of CEA for managed care pharmacists in formulary decision-making.

Main Methods:

  • Review of existing literature on cost-effectiveness analysis (CEA).
  • Discussion of methodological enhancements, including modeling software, rank-order stability analysis, cost-consequence analysis (CCA), and budget impact analysis.

Related Experiment Videos

  • Consideration of combined CCA-CEA methods and standardized guidelines.

    • Main Results:

    • Current limitations in CEA methodology impact its practical contribution to formulary decisions.
    • Proposed enhancements and combined methods (CCA-CEA) can improve CEA's impact.
    • Standardized guidelines are crucial for enhancing CEA's role.

    Conclusions:

    • Cost-effectiveness analysis (CEA) is essential for balancing cost containment and quality of care in managed care.
    • Methodological advancements and standardized guidelines will increase CEA's importance in formulary decision-making.
    • Improved CEA utility supports informed decisions for drug formulary systems.